Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC10451 structure
    GC10451U-73122
    CAS: 112648-68-7
    纯度: >98.00%

    U-73122是有效的、选择性的磷脂酶C(PLC)抑制剂,IC 50 值约为1-2.1μM,也可抑制5-脂氧合酶(5-LO)。

  • GC10592 structure
    GC10592IKK-3 Inhibitor
    CAS: 862812-98-4
    纯度: >98.50%

    A multi-kinase inhibitor

  • GC10692 structure
    GC10692Caffeic Acid Phenethyl Ester
    CAS: 104594-70-9
    纯度: >98.00%

    Caffeic Acid Phenethyl Ester是一种天然存在蜂胶中的苯丙素类化合物,具有多种生物学活性。

  • GC10712 structure
    GC10712Imiquimod hydrochloride
    CAS: 99011-78-6
    纯度: >99.50%

    A TLR7 agonist

  • GC10933 structure
    GC10933Sodium 4-Aminosalicylate
    CAS: 6018-19-5
    纯度: >99.50%

    4-氨基水杨酸钠(4-氨基水杨酸钠盐二水合物)是目前用于耐多药结核病的抗分枝杆菌药物之一。

  • GC11170 structure
    GC11170Choline Fenofibrate
    CAS: 856676-23-8
    纯度: >98.00%

    非诺贝特胆碱 (ABT-335) 是一种非诺贝酸的胆碱盐,可在胃肠道中释放游离的非诺贝酸。

  • GC11294 structure
    GC11294TAK-242 S enantiomer
    CAS: 243984-10-3
    纯度: >98.00%

    TLR 4 signaling inhibitor

  • GC11438 structure
    GC11438JSH-23
    CAS: 749886-87-1
    纯度: >99.00%

    JSH-23 对核转位和 NF-κB 转录活性具有抑制作用,在脂多糖 (LPS) 刺激的巨噬细胞中 IC50 值为 7.1 μM RAW 264.7 。

  • GC11719 structure
    GC11719HG-9-91-01
    CAS: 1456858-58-4
    纯度: >99.00%

    An inhibitor of salt-inducible kinases

  • GC11751 structure
    GC11751QNZ (EVP4593)
    CAS: 545380-34-5
    纯度: >98.00%

    QNZ (EVP4593)是一种高效、选择性核因子κB(NF-κB)信号通路抑制剂,IC 50 值为11nM,具有抗炎功效。

  • GC11819 structure
    GC11819Strontium Ranelate
    CAS: 135459-87-9
    纯度: >99.50%

    An antiosteoporotic agent

  • GC12013 structure
    GC12013Sodium salicylate
    CAS: 54-21-7
    纯度: >99.50%

    水杨酸钠(水杨酸钠盐)抑制环加氧酶 2(COX-2)活性,与转录因子(NF-κB)激活无关。

  • GC12180 structure
    GC12180IKK-16 (IKK Inhibitor VII)
    CAS: 873225-46-8
    纯度: >99.00%

    IKK-16 (IKK Inhibitor VII)是一种新型的、具有口服活性的选择性IκB激酶(IKK)抑制剂,IKK-16作用于IKK-2、IKK复合物和IKK-1的IC 50 值分别为40nM、70nM和200nM

  • GC12645 structure
    GC12645Imiquimod maleate
    CAS: 896106-16-4
    纯度: >98.00%

    A TLR7 agonist

  • GC13035 structure
    GC13035Bay 11-7821
    CAS: 19542-67-7
    纯度: >99.50% / >95.00%

    Bay 11-7821是一种IκBα磷酸化和NF-κB抑制剂,选择性且不可逆地抑制TNF-α诱导的IκB-α磷酸化(IC 50 值约为10μM),并减少NF-κB和粘附分子的表达。Bay 11-7821抑制泛素特异性蛋白酶USP7和USP21,IC 50 分别为0.19、0.96μM。

  • GC13066 structure
    GC13066Y-320
    CAS: 288250-47-5
    纯度: >99.00%

    An inhibitor of IL-15-mediated CD4 T cell activation

  • GC13650 structure
    GC13650Resiquimod (R-848)
    CAS: 144875-48-9
    纯度: >99.50%

    Resiquimod (R848)是一种具有潜在抗病毒活性的咪唑喹啉类化合物。

  • GC14352 structure
    GC14352TAT 14
    CAS: 1362661-34-4
    纯度: >98.00%

    TAT 14 是一种 14 聚体肽,可作为具有抗炎作用的 Nrf2 激活剂。

  • GC14402 structure
    GC14402Triptolide
    CAS: 38748-32-2
    纯度: >99.50% / >99.00% / >98.00%

    雷公藤甲素(Triptolide)是一种二萜三环氧化物,首次从药用植物雷公藤 (Tripterygium wilfordii) 中分离出来,具有免疫抑制,抗炎,抗增殖和抗肿瘤作用。

  • GC14435 structure
    GC14435Zileuton sodium
    CAS: 118569-21-4

    A reversible inhibitor of 5-lipoxygenase

  • GC14438 structure
    GC14438Suprofen
    CAS: 40828-46-4
    纯度: >99.50%

    A non-selective NSAID

  • GC14633 structure
    GC14633HPGDS inhibitor 1
    CAS: 1033836-12-2
    纯度: >99.00%

    An inhibitor H-PGDS

  • GC14751 structure
    GC14751Malotilate
    CAS: 59937-28-9
    纯度: >99.50%

    A hepatoprotective agent

  • GC14787 structure
    GC14787Curcumin
    CAS: 458-37-7
    纯度: >98.00%

    A yellow pigment with diverse biological activities